The miR-193a-3p-regulated ING5 gene activates the DNA damage response pathway and inhibits multi-chemoresistance in bladder cancer. - Wikidata - wikimedia - TriplyDB

The miR-193a-3p-regulated ING5 gene activates the DNA damage response pathway and inhibits multi-chemoresistance in bladder cancer.

The miR-193a-3p-regulated ING5 gene activates the DNA damage response pathway and inhibits multi-chemoresistance in bladder cancer.

http://www.wikidata.org/entity/Q35832954

about

Epigenetics of Aging and Alzheimer's Disease: Implications for Pharmacogenomics and Drug Response Expression and Clinical Pathological Significance of miR-200a in Concurrent Cholangiocarcinoma Associated with Hepatolithiasis Arm Selection Preference of MicroRNA-193a Varies in Breast Cancer.Conditional ablation of TGF-β signaling inhibits tumor progression and invasion in an induced mouse bladder cancer model.MiR-193a-5p Targets the Coding Region of AP-2α mRNA and Induces Cisplatin Resistance in Bladder Cancers MicroRNA-31 functions as a tumor suppressor and increases sensitivity to mitomycin-C in urothelial bladder cancer by targeting integrin α5.MicroRNA-206 acts as a tumor suppressor in bladder cancer via targeting YRDC.MiR-1307 promotes ovarian cancer cell chemoresistance by targeting the ING5 expression Immunosuppressive effect of bladder cancer on function of dendritic cells involving of Jak2/STAT3 pathway Emerging genotype-phenotype relationships in patients with large NF1 deletions.Influence of microRNAs and Long Non-Coding RNAs in Cancer Chemoresistance.INGs are potential drug targets for cancer.The roles of ING5 in gliomas: a good marker for tumorigenesis and a potential target for gene therapy.miR-125b suppresses the proliferation of hepatocellular carcinoma cells by targeting Sirtuin7.Biological Function of MicroRNA193a-3p in Health and Disease.MicroRNA-193a inhibits breast cancer proliferation and metastasis by downregulating WT1 The nucleocytoplasmic translocation and up-regulation of ING5 protein in breast cancer: a potential target for gene therapy.The roles of ING5 expression in ovarian carcinogenesis and subsequent progression: a target of gene therapy.LncRNA lnc-RI regulates homologous recombination repair of DNA double-strand breaks by stabilizing RAD51 mRNA as a competitive endogenous RNA.CBFA2T2 is associated with a cancer stem cell state in renal cell carcinoma.Excess of a Rassf1-targeting microRNA, miR-193a-3p, perturbs cell division fidelity.ING5-mediated antineuroblastoma effects of suberoylanilide hydroxamic acid

P2860

Q26772028-40A5AA25-8716-4D39-89F4-445553F55413 Q36314718-277CCB71-8466-4152-9EDF-C65F7A77BF87 Q37010560-A42F9CBD-BB08-45BC-9DCC-F7F1520863F0 Q37063904-1B1723F4-3D3A-4343-A505-23785AA8B7F5 Q37290580-78E04D7C-6D20-4AEE-915D-31E1627B545E Q37317285-C82DB230-4F10-41ED-B57B-B6BBDA6313C3 Q37448112-98F694F7-4E5F-4639-8A62-8ED6EB46837B Q37584834-5BECF18D-6775-4793-A9D8-190694D61DFC Q37665296-F9B6496B-2B7D-48CE-B90D-D963326A4A7F Q37725901-627028F3-A2B5-44CF-93CA-0BEC61C95778 Q38546133-1FD8EC8F-932C-4887-95F7-39882D123723 Q38932782-3D44B945-64ED-440B-B2C5-FDC9F71E558D Q41345808-599401D8-6BF5-4556-B031-D38C5A42ADA6 Q41571157-C0AB414C-7465-4971-918F-7790B7FD4312 Q42361167-6F32DDE1-638B-43D9-A617-B786AD4214BB Q42706828-CD389839-3378-49DC-8CA8-3579371A9BBE Q45874456-0DB6253E-EE4C-4375-A770-EA7B52CF145C Q47094216-D683C9D8-F4AC-4AA1-9520-AD02B2A5315F Q47319367-14C73FFD-51F1-41E4-9425-FC32B09F57CC Q47432809-6F4DAAC1-4347-4A4A-960C-20861940C689 Q50695888-4349F2B0-BD52-40A5-95EC-816AF7867439 Q58792092-7E1865B5-38AA-477E-BE44-5AFD3536576E

P2860

The miR-193a-3p-regulated ING5 gene activates the DNA damage response pathway and inhibits multi-chemoresistance in bladder cancer.

http://www.wikidata.org/entity/Q35832954

description

2015 nî lūn-bûn

@nan

2015年の論文

@ja

2015年学术文章

@wuu

2015年学术文章

@zh-cn

2015年学术文章

@zh-hans

2015年学术文章

@zh-my

2015年学术文章

@zh-sg

2015年學術文章

@yue

2015年學術文章

@zh

2015年學術文章

@zh-hant

name

The miR-193a-3p-regulated ING5 ...... oresistance in bladder cancer.

@ast

The miR-193a-3p-regulated ING5 ...... oresistance in bladder cancer.

@en

type

label

The miR-193a-3p-regulated ING5 ...... oresistance in bladder cancer.

@ast

The miR-193a-3p-regulated ING5 ...... oresistance in bladder cancer.

@en

prefLabel

The miR-193a-3p-regulated ING5 ...... oresistance in bladder cancer.

@ast

The miR-193a-3p-regulated ING5 ...... oresistance in bladder cancer.

@en

P1433

Q35832954-6EBEAF4B-7FF2-412D-B4DD-0D2E4E9D0861

P1476

Q35832954-F055AF67-E789-4A44-B2F7-C7AB360D749E

P2093

Q35832954-133D96BB-140A-4FC8-8880-1DD2FEC7CA1B

Q35832954-4E60FA32-FE1A-4B7A-BBEA-98A912330709

Q35832954-4FA553CD-2330-43A1-B8F2-5C26650171FB

Q35832954-59EE2B66-9FA4-45FD-8365-2DBEBBF36946

Q35832954-67B3EFA3-DBE6-4FD2-B4DB-45FE93E1F13C

Q35832954-6BFCE56D-E674-481F-9EF2-B98B49F1A855

Q35832954-94A63B25-3765-4691-9C05-64006D3D2F21

Q35832954-B08AD5A3-1DFD-4338-9885-1F52A4B99B9B

Q35832954-C4247A86-0609-4C19-B438-2BD58978ED1C

Q35832954-DEA54412-DFF2-452F-8AD5-5370F1E1569D

P2860

Q35832954-022C23BF-983E-4EF9-9B79-E78E7A6495D6

Q35832954-0A1CE128-F73D-4A0B-9740-7696DAA7AE9F

Q35832954-0C37FB89-F050-4DE6-AB80-02D619B0D1C9

Q35832954-16860F88-E665-4958-86CF-FAA4EB1F3725

Q35832954-1CE5F1E5-999F-4003-9028-3A35F7EE8C18

Q35832954-1D819B79-C90F-416C-9A9E-1CAB267472C5

Q35832954-2B7F0EDC-3F05-4456-810A-DD40455F7D62

Q35832954-2D480C39-DD4C-4EDE-8195-F518B46973A9

Q35832954-313988CD-EB89-4E4B-82A8-20AC674F886B

Q35832954-3596E0B6-9183-477A-BF84-3D939C42E0D5

P304

Q35832954-D5D4D453-BBD3-4C79-94CF-BFB4D2F136C0

P31

Q35832954-189763CC-7E2B-4306-8816-90C99A22DD87

P356

Q35832954-A6749AE9-3665-4409-9CD3-01D9EFF908CE

P407

Q35832954-59995608-7725-49A7-9236-EF1E649C0695

P433

Q35832954-FA96E9CE-9A88-433B-87AA-2396E39AFBD5

P478

Q35832954-C8EEA6D2-5899-4D6F-A129-D88FE60F559E

P50

Q35832954-C261CEF1-FBDC-4F9B-9474-4B26F38AFD78

P577

Q35832954-0A966F63-610F-4966-ABBC-9723F766B083

P5875

Q35832954-20A96D86-E858-423A-BD11-D9EE1C1DE926

P698

Q35832954-EAD4FA47-0A66-4D34-B013-B74B8B858326

P921

Q35832954-12532675-EB87-4E0A-BF62-B2D8461D62C6

Q35832954-F38B1E17-8AEF-4D31-87A9-8753B6FB81CD

P932

Q35832954-8F1A583F-0F72-4996-8DF3-6776222EDA6A

P356

ONCOTARGET.3555

P1433

P1476

The miR-193a-3p-regulated ING5 ...... moresistance in bladder cancer

@en

P2093

Cheng Zhang

http://www.w3.org/2001/XMLSchema#string

Daming Zhang

http://www.w3.org/2001/XMLSchema#string

Hongyu Zhang

http://www.w3.org/2001/XMLSchema#string

Hui Deng

http://www.w3.org/2001/XMLSchema#string

Jingde Zhu

http://www.w3.org/2001/XMLSchema#string

Jun Xiao

http://www.w3.org/2001/XMLSchema#string

Lei Lv

http://www.w3.org/2001/XMLSchema#string

Liting Qian

http://www.w3.org/2001/XMLSchema#string

Qi Liu

http://www.w3.org/2001/XMLSchema#string

Weidong Zhao

http://www.w3.org/2001/XMLSchema#string

P2860

ING tumor suppressor proteins are critical regulators of chromatin acetylation required for genome expression and perpetuation

p29ING4 and p28ING5 bind to p53 and p300, and enhance p53 activity

Molecular architecture of quartet MOZ/MORF histone acetyltransferase complexes

Intratumor Heterogeneity and Branched Evolution Revealed by Multiregion Sequencing

Cancer statistics, 2014

Divorcing ARF and p53: an unsettled case

The c-MYC oncoprotein is a substrate of the acetyltransferases hGCN5/PCAF and TIP60

Hbo1 Links p53-dependent stress signaling to DNA replication licensing.

Downregulation of HIPK2 increases resistance of bladder cancer cell to cisplatin by regulating Wip1

The ING gene family in the regulation of cell growth and tumorigenesis.

P304

10195-10206

http://www.w3.org/2001/XMLSchema#string

P31

scholarly article

P356

10.18632/ONCOTARGET.3555

http://www.w3.org/2001/XMLSchema#string

P407

P433

12

http://www.w3.org/2001/XMLSchema#string

P478

6

http://www.w3.org/2001/XMLSchema#string

P50

P577

2015-04-01T00:00:00Z

http://www.w3.org/2001/XMLSchema#dateTime

P5875

277085007

http://www.w3.org/2001/XMLSchema#string

P698

25991669

http://www.w3.org/2001/XMLSchema#string

P921

P932

4496349

http://www.w3.org/2001/XMLSchema#string